297 related articles for article (PubMed ID: 26432520)
1. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
3. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
[TBL] [Abstract][Full Text] [Related]
6. Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.
Rempel RE; Jiang X; Fullerton P; Tan TZ; Ye J; Lau JA; Mori S; Chi JT; Nevins JR; Friedman DR
Mol Cancer Ther; 2014 Dec; 13(12):3219-29. PubMed ID: 25349303
[TBL] [Abstract][Full Text] [Related]
7. Pathology consultation on intermediate-to-large B-cell lymphomas.
Montgomery ND; Fedoriw Y
Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
[TBL] [Abstract][Full Text] [Related]
8. Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Waibel M; Gregory G; Shortt J; Johnstone RW
Curr Opin Hematol; 2014 Jul; 21(4):297-308. PubMed ID: 24811162
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma.
Dybkaer K; Iqbal J; Zhou G; Chan WC
Clin Lymphoma; 2004 Jun; 5(1):19-28. PubMed ID: 15245604
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
Fu K; Iqbal J; Chan WC
Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
[TBL] [Abstract][Full Text] [Related]
12. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
Weber T; Schmitz R
Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
14. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
15. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
Kwok M; Wu SP; Mo C; Summers T; Roschewski M
Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
19. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Glass S; Phan A; Williams JN; Flowers CR; Koff JL
Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
[TBL] [Abstract][Full Text] [Related]
20. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.
de Jong D; Balagué Ponz O
J Pathol; 2011 Jan; 223(2):274-82. PubMed ID: 21125680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]